Report Cover

United States Gastrointestinal Market Report & Forecast 2021-2027


United States Gastrointestinal Market, By Type, 2016-2021, 2022-2027 ($ Millions)
United States Gastrointestinal Market Segment Percentages, By Type, 2020 (%)
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug

United States Gastrointestinal Market, By Application, 2016-2021, 2022-2027 ($ Millions)
United States Gastrointestinal Market Segment Percentages, By Application, 2020 (%)
    Chronic Gastritis
    Functional Dyspepsia
    Peptic Ulcer
    Acute Gastroenteritis
    Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Gastrointestinal revenues share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    AstraZenec
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria(Tillotts)
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen
1 Introduction to Research & Analysis Reports
    1.1 Gastrointestinal Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Gastrointestinal Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Gastrointestinal Overall Market Size
    2.1 United States Gastrointestinal Market Size: 2021 VS 2027
    2.2 United States Gastrointestinal Revenue, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints

3 Company Landscape
    3.1 Top Gastrointestinal Players in United States Market
    3.2 Top United States Gastrointestinal Companies Ranked by Revenue
    3.3 United States Gastrointestinal Revenue by Companies
    3.4 Top 3 and Top 5 Gastrointestinal Companies in United States Market, by Revenue in 2020
    3.5 Companies Gastrointestinal Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Players in United States Market
        3.6.1 List of Tier 1 Gastrointestinal Companies in United States
        3.6.2 List of Tier 2 and Tier 3 Gastrointestinal Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Gastrointestinal Market Size Markets, 2021 & 2027
        4.1.2 Prescription Gastrointestinal Drug
        4.1.3 OTC Gastrointestinal Drug
    4.2 By Type - United States Gastrointestinal Revenue & Forecasts
        4.2.1 By Type - United States Gastrointestinal Revenue, 2016-2021
        4.2.2 By Type - United States Gastrointestinal Revenue, 2022-2027
        4.2.3 By Type - United States Gastrointestinal Revenue Market Share, 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Gastrointestinal Market Size, 2021 & 2027
        5.1.2 Chronic Gastritis
        5.1.3 Functional Dyspepsia
        5.1.4 Peptic Ulcer
        5.1.5 Acute Gastroenteritis
        5.1.6 Others
    5.2 By Application - United States Gastrointestinal Revenue & Forecasts
        5.2.1 By Application - United States Gastrointestinal Revenue, 2016-2021
        5.2.2 By Application - United States Gastrointestinal Revenue, 2022-2027
        5.2.3 By Application - United States Gastrointestinal Revenue Market Share, 2016-2027

6 Gastrointestinal Companies Profiles
    6.1 AstraZenec
        6.1.1 AstraZenec Company Details
        6.1.2 AstraZenec Business Overview
        6.1.3 AstraZenec Gastrointestinal Introduction
        6.1.4 AstraZenec Gastrointestinal Revenue in United States Market (2016-2021)
        6.1.5 AstraZenec Recent Developments
    6.2 Sanofi
        6.2.1 Sanofi Company Details
        6.2.2 Sanofi Business Overview
        6.2.3 Sanofi Gastrointestinal Introduction
        6.2.4 Sanofi Gastrointestinal Revenue in United States Market (2016-2021)
        6.2.5 Sanofi Recent Developments
    6.3 Bayer
        6.3.1 Bayer Company Details
        6.3.2 Bayer Business Overview
        6.3.3 Bayer Gastrointestinal Introduction
        6.3.4 Bayer Gastrointestinal Revenue in United States Market (2016-2021)
        6.3.5 Bayer Recent Developments
    6.4 Pfizer
        6.4.1 Pfizer Company Details
        6.4.2 Pfizer Business Overview
        6.4.3 Pfizer Gastrointestinal Introduction
        6.4.4 Pfizer Gastrointestinal Revenue in United States Market (2016-2021)
        6.4.5 Pfizer Recent Developments
    6.5 GlaxoSmithKline
        6.5.1 GlaxoSmithKline Company Details
        6.5.2 GlaxoSmithKline Business Overview
        6.5.3 GlaxoSmithKline Gastrointestinal Introduction
        6.5.4 GlaxoSmithKline Gastrointestinal Revenue in United States Market (2016-2021)
        6.5.5 GlaxoSmithKline Recent Developments
    6.6 Teva
        6.6.1 Teva Company Details
        6.6.2 Teva Business Overview
        6.6.3 Teva Gastrointestinal Introduction
        6.6.4 Teva Gastrointestinal Revenue in United States Market (2016-2021)
        6.6.5 Teva Recent Developments
    6.7 Zeria(Tillotts)
        6.7.1 Zeria(Tillotts) Company Details
        6.7.2 Zeria(Tillotts) Business Overview
        6.7.3 Zeria(Tillotts) Gastrointestinal Introduction
        6.7.4 Zeria(Tillotts) Gastrointestinal Revenue in United States Market (2016-2021)
        6.7.5 Zeria(Tillotts) Recent Developments
    6.8 Perrigo
        6.8.1 Perrigo Company Details
        6.8.2 Perrigo Business Overview
        6.8.3 Perrigo Gastrointestinal Introduction
        6.8.4 Perrigo Gastrointestinal Revenue in United States Market (2016-2021)
        6.8.5 Perrigo Recent Developments
    6.9 Boehringer Ingelheim
        6.9.1 Boehringer Ingelheim Company Details
        6.9.2 Boehringer Ingelheim Business Overview
        6.9.3 Boehringer Ingelheim Gastrointestinal Introduction
        6.9.4 Boehringer Ingelheim Gastrointestinal Revenue in United States Market (2016-2021)
        6.9.5 Boehringer Ingelheim Recent Developments
    6.10 Purdue Pharma
        6.10.1 Purdue Pharma Company Details
        6.10.2 Purdue Pharma Business Overview
        6.10.3 Purdue Pharma Gastrointestinal Introduction
        6.10.4 Purdue Pharma Gastrointestinal Revenue in United States Market (2016-2021)
        6.10.5 Purdue Pharma Recent Developments
    6.11 C.B. Fleet
        6.11.1 C.B. Fleet Company Details
        6.11.2 C.B. Fleet Business Overview
        6.11.3 C.B. Fleet Gastrointestinal Introduction
        6.11.4 C.B. Fleet Gastrointestinal Revenue in United States Market (2016-2021)
        6.11.5 C.B. Fleet Recent Developments
    6.12 Abbott
        6.12.1 Abbott Company Details
        6.12.2 Abbott Business Overview
        6.12.3 Abbott Gastrointestinal Introduction
        6.12.4 Abbott Gastrointestinal Revenue in United States Market (2016-2021)
        6.12.5 Abbott Recent Developments
    6.13 Jiangzhong
        6.13.1 Jiangzhong Company Details
        6.13.2 Jiangzhong Business Overview
        6.13.3 Jiangzhong Gastrointestinal Introduction
        6.13.4 Jiangzhong Gastrointestinal Revenue in United States Market (2016-2021)
        6.13.5 Jiangzhong Recent Developments
    6.14 Xian-Janssen
        6.14.1 Xian-Janssen Company Details
        6.14.2 Xian-Janssen Business Overview
        6.14.3 Xian-Janssen Gastrointestinal Introduction
        6.14.4 Xian-Janssen Gastrointestinal Revenue in United States Market (2016-2021)
        6.14.5 Xian-Janssen Recent Developments

7 Conclusion
8 Appendix
    8.1 Note
    8.2 Examples of Clients
    8.3 Author Details
    8.4 Disclaimer

List of Tables Table 1. Gastrointestinal Market Opportunities & Trends in United States Market Table 2. Gastrointestinal Market Drivers in United States Market Table 3. Gastrointestinal Market Restraints in United States Market Table 4. Key Players of Gastrointestinal in United States Market Table 5. Top Gastrointestinal Players in United States Market, Ranking by Revenue (2019) Table 6. United States Gastrointestinal Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Gastrointestinal Revenue Share by Companies, 2016-2021 Table 8. Companies Gastrointestinal Product Type Table 9. List of Tier 1 Gastrointestinal Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Gastrointestinal Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type - United States Gastrointestinal Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Gastrointestinal Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Gastrointestinal Revenue (US$, Mn), 2022-2027 Table 14. By Application - United States Gastrointestinal Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Gastrointestinal Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Gastrointestinal Revenue (US$, Mn), 2022-2027 Table 17. AstraZenec Company Details Table 18. AstraZenec Business Overview Table 19. AstraZenec Gastrointestinal Product Table 20. AstraZenec Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 21. AstraZenec Recent Developments Table 22. Sanofi Company Details Table 23. Sanofi Business Overview Table 24. Sanofi Gastrointestinal Product Table 25. Sanofi Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Sanofi Recent Developments Table 27. Bayer Company Details Table 28. Bayer Business Overview Table 29. Bayer Gastrointestinal Product Table 30. Bayer Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Bayer Recent Developments Table 32. Pfizer Company Details Table 33. Pfizer Business Overview Table 34. Pfizer Gastrointestinal Product Table 35. Pfizer Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Pfizer Recent Developments Table 37. GlaxoSmithKline Company Details Table 38. GlaxoSmithKline Business Overview Table 39. GlaxoSmithKline Gastrointestinal Product Table 40. GlaxoSmithKline Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 41. GlaxoSmithKline Recent Developments Table 42. Teva Company Details Table 43. Teva Business Overview Table 44. Teva Gastrointestinal Product Table 45. Teva Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Teva Recent Developments Table 47. Zeria(Tillotts) Company Details Table 48. Zeria(Tillotts) Business Overview Table 49. Zeria(Tillotts) Gastrointestinal Product Table 50. Zeria(Tillotts) Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Zeria(Tillotts) Recent Developments Table 52. Perrigo Company Details Table 53. Perrigo Business Overview Table 54. Perrigo Gastrointestinal Product Table 55. Perrigo Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 56. Perrigo Recent Developments Table 57. Boehringer Ingelheim Company Details Table 58. Boehringer Ingelheim Business Overview Table 59. Boehringer Ingelheim Gastrointestinal Product Table 60. Boehringer Ingelheim Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 61. Boehringer Ingelheim Recent Developments Table 62. Purdue Pharma Company Details Table 63. Purdue Pharma Business Overview Table 64. Purdue Pharma Gastrointestinal Product Table 65. Purdue Pharma Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 66. Purdue Pharma Recent Developments Table 67. C.B. Fleet Company Details Table 68. C.B. Fleet Business Overview Table 69. C.B. Fleet Gastrointestinal Product Table 70. C.B. Fleet Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 71. C.B. Fleet Recent Developments Table 72. Abbott Company Details Table 73. Abbott Business Overview Table 74. Abbott Gastrointestinal Product Table 75. Abbott Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 76. Abbott Recent Developments Table 77. Jiangzhong Company Details Table 78. Jiangzhong Business Overview Table 79. Jiangzhong Gastrointestinal Product Table 80. Jiangzhong Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 81. Jiangzhong Recent Developments Table 82. Xian-Janssen Company Details Table 83. Xian-Janssen Business Overview Table 84. Xian-Janssen Gastrointestinal Product Table 85. Xian-Janssen Gastrointestinal Revenue in United States Market (2016-2021) & (US$ Million) Table 86. Xian-Janssen Recent Developments List of Figures Figure 1. Gastrointestinal Segment by Type Figure 2. Gastrointestinal Segment by Application Figure 3. United States Gastrointestinal Market Overview: 2020 Figure 4. United States Gastrointestinal Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Gastrointestinal Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Gastrointestinal Revenue in 2020 Figure 7. By Type - United States Gastrointestinal Revenue Market Share, 2016-2027 Figure 8. By Application - United States Gastrointestinal Revenue Market Share, 2016-2027 Figure 9. AstraZenec Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Sanofi Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Bayer Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Pfizer Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. GlaxoSmithKline Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Teva Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Zeria(Tillotts) Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Perrigo Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. Boehringer Ingelheim Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. Purdue Pharma Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 19. C.B. Fleet Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 20. Abbott Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Jiangzhong Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Xian-Janssen Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us